Valery Volk is a biomarker researcher with a PhD from Hannover Medical School. There he worked in the Digital Pathology group, using image analysis to read tissue and immune markers for cancer and transplant diagnostics.
Dr. Valery Volk
Biomarker Researcher, Digital Pathology
Biomarker Researcher, Hannover · Hamburg chapter
Valery Volk is a biomarker researcher with a PhD from Hannover Medical School, where he worked in digital pathology on tissue markers for cancer and transplant diagnostics. At Longevity Hamburg he explained which longevity biomarkers actually matter.
Highlights
- Biomarker, immunology and digital-pathology research cited more than 800 times (Google Scholar).
- Co-authored the clinical trial paper on olamkicept for inflammatory bowel disease (Gastroenterology, 2021), cited over 300 times.
- Worked in the Digital Pathology group at Hannover Medical School, which builds image-analysis methods that read tissue biomarkers for transplant and cancer diagnostics.
Biomarker, immunology and digital-pathology research cited more than 800 times (Google Scholar).. Co-authored the clinical trial paper on olamkicept for inflammatory bowel disease (Gastroenterology, 2021), cited over 300 times.. Worked in the Digital Pathology group at Hannover Medical School, which builds image-analysis methods that read tissue biomarkers for transplant and cancer diagnostics..
About Valery Volk
Valery Volk works with biomarkers: the measurable signals in blood, tissue and images that tell you what is happening inside a body. He earned his PhD at Hannover Medical School (MHH).
At MHH he worked in the Digital Pathology group led by Prof. Friedrich Feuerhake. The team builds image-analysis methods that read immune cells and tissue markers, mostly for kidney transplants and cancer. In plain terms: teaching software to spot patterns a human eye would miss.
His published work has been cited more than 800 times. It ranges from a clinical trial of the drug olamkicept for inflammatory bowel disease to CAR-T cells engineered against the Epstein-Barr virus. The common thread is finding the right marker to guide the right treatment.
On 26 April 2026 he gave the talk "Biomarkers of Longevity: General overview and practical hints" at Longevity Hamburg in Hamburg. He brought that lens to healthy aging: which biomarkers actually matter, what to test and when, and why a trend over time beats a single blood panel. The talk argued for science over guesswork and against over-optimizing.
Credentials
- PhDPhD— Hannover Medical School (MHH)
Topics & Expertise
- Epigenetics & Biomarkers
- Preventive Medicine
- Aging Biology & Senolytics
- longevity biomarkers
- multiplex immunohistochemistry
- digital pathology
- biomarker-guided diagnostics
- immune microenvironment analysis
- transplant and cancer pathology
- blood, dna and imaging-based health metrics
Talks at Longevity Austria
Past
- Biomarkers of Longevity: General overview and practical hints — Apr 26, 2026 · Onetwo — Yoga & Co., Buchenstraße 3, 22299 Hamburg, Germany
Frequently asked questions
Who is Valery Volk?
What did Valery Volk speak about at Longevity Hamburg?
He gave a practical overview of biomarkers of longevity: which markers actually matter, what to test and at what age, what blood tests, DNA analysis, DEXA scans and wearables can and cannot tell you, and why trends over time beat a single snapshot.
What is Valery Volk's scientific background?
He holds a PhD from Hannover Medical School and has worked in digital pathology and translational biomarker research. His published work spans transplant medicine, oncology and immunology, including studies on multiplex immunohistochemistry, kidney transplant biopsies and CAR-T cell therapy.
Where has Valery Volk spoken for Longevity Cities?
He gave the talk "Biomarkers of Longevity: General overview and practical hints" at Longevity Hamburg on 26 April 2026, at Onetwo in Hamburg.